Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma (vol 126, pg 93, 2020)
Author(s):
Decaudin, D.; Leitz, E.F.D.; Nemati, F.; Tarin, M.; Naguez, A.; Zerara, M.; Marande, B.; Vivet-Noguer, R.; Halilovic, E.; Fabre, C.; Jochemsen, A.; -Roman, S.R.; Alsafadi, S.
Published
2023
Publication type
Article / Letter to editor
Date issued
2023-04-11
Language
English
Publisher
Elsevier
Is part of
European Journal of Cancer (2023), Vol. 184, p. 199-199
